Explore more publications!

Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on March 10, 2026

Denodo Platform 9.4 accélère le déploiement en production de l’IA agentique
Denodo Platform 9.4 מאיצה את הדרך לייצור מוצלח של בינה מלאכותית סוכנית
Denodo Platform 9.4 加速邁向成功的代理型 AI 生產應用之路
デノード・プラットフォーム9.4、エージェント型AIの本番環境導入成功への道程をスピードアップ
Denodo Platform 9.4, 에이전트형 AI 프로덕션의 성공 가속화한다
Denodo Platform 9.4 加速实现智能体 AI 的成功落地
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
Kodiak AI Announces Fourth Quarter and Full Year 2025 Results
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
Simulation Learning Market to Grow at 16.4% CAGR During 2026–2030, Reaching $53.5 Billion by 2030
Corporate Identity Design Market - Analysis of Opportunities, Market Share, Growth, Competition, and Forecast Until 2030
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
TP Positions Itself at the Forefront of AI-Driven CX With TP Forward AI CX Roundtable Series

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions